Girth and Firmness: Why Blood Retention Affects How Full an Erection Is

Men using a constriction ring often describe the erection as feeling fuller or thicker, not only firmer. This article explains the mechanism behind that, and what can and cannot be claimed about it.

The relevant anatomy

The penis contains three erectile bodies: the paired corpora cavernosa, which produce the rigidity of the shaft, and the corpus spongiosum, which surrounds the urethra and forms the glans. These are enclosed in layers of connective tissue, including Buck's fascia, the superficial fascia, and the loose areolar tissue between them.

During arousal, the arteries dilate and blood fills the erectile tissue. As that tissue expands, it compresses the draining veins against the tunica albuginea, the fibrous sheath around the corpora. This compression is what retains the blood.

In veno-occlusive dysfunction, that compression is incomplete. Blood drains faster than it arrives, and the erectile tissue does not reach full expansion. On penile duplex ultrasound this appears as persistently elevated end-diastolic velocity.

Why retention affects girth

When venous outflow is reduced, intracavernosal pressure is higher than it would otherwise be. That pressure is transmitted outward to the surrounding tissue layers, which are relatively loose at rest and become distended as pressure rises.

The practical consequence is that girth in an erection is not fixed. It depends on how completely the tissue expands, and that depends on retention as much as on inflow. A man with venous leak may achieve partial rigidity without reaching the girth his anatomy allows.

This is a description of penile hemodynamics, not a claim about enlargement. Nothing about a constriction ring changes the anatomy of the penis. What changes is how completely the existing tissue fills during use, and the effect lasts only while the device is in place.

How the anchoring design relates

A conventional constriction ring must be tight to occlude, and can shift during intercourse, at which point occlusion is reduced. Xialla is held in position by an anchoring loop that passes around the scrotum and connects to a band at the lower back, so it maintains position without relying on circumferential tightness.

More consistent occlusion means more consistent retention, which is the mechanism described above. Further detail: how Xialla reduces venous outflow.

How this differs from other treatments

PDE5 inhibitors, intracavernosal injections, and intraurethral therapy all act by increasing arterial inflow. In a man whose retention is impaired, increased inflow may produce partial rigidity without full tissue expansion.

A vacuum erection device draws blood in mechanically and uses a constriction ring at the base to retain it. In that combination the ring performs the retention function, which is the same mechanism described here.

The distinction is between treatments that act on inflow and those that act on outflow, not between better and worse treatments. Which is appropriate depends on which side of the mechanism is impaired, and that is a question for a urologist. Our guide to venous leak covers how the two are distinguished.

What the evidence supports

Xialla's published evidence addresses erectile function and blood retention: a 2016 trial reporting improved erectile function in 14 of 21 patients, a subsequent trial reporting salvage in 6 of 11 men with veno-occlusive dysfunction, and a perspective article in the International Journal of Impotence Research which notes that larger multicentre trials are needed.

Girth has not been measured in these studies. The relationship between venous occlusion and tissue expansion is established penile physiology, and men who use the device report a fuller erection, but the specific effect on girth has not been quantified in published research. We would rather state that than imply otherwise.

Who this is most relevant to

The mechanism is most relevant to men whose erectile difficulty involves impaired retention rather than impaired inflow: erections that begin adequately and fade, loss of firmness on changing position, or a partial response to oral medication. It is also relevant to men who have noticed reduced fullness following prostate surgery.

It is not relevant to men whose primary problem is arterial. If you have not had an evaluation, that is the place to start.

Safe use

Observe a maximum of 30 minutes of continuous wear, remove the device before sleeping, and remove it immediately if numbness, coldness, discolouration, or pain occurs. Men taking anticoagulants, men with sickle cell disease, and men with reduced penile sensation should consult a physician before use.

A tighter device does not produce a better result. Excessive compression restricts arterial inflow, which reduces tissue expansion rather than increasing it. If the device feels tight, it is the wrong size.

References

• Dean RC, Lue TF. Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction. Urol Clin North Am. 2005.
• Rebonato A, et al. Embolization of the Periprostatic Venous Plexus for Erectile Dysfunction Resulting from Venous Leakage. J Vasc Interv Radiol. 2014.
• Diehm N, et al. Venous Leak Embolization in Patients with Venogenic Erectile Dysfunction. CVIR Endovascular. 2023.
• Yafi FA, Hammad MAM, Elterman D. Xialla: a novel medical device for addressing erectile dysfunction associated with veno-occlusive dysfunction. Int J Impot Res. 2024.